Octagon Capital Advisors as of Dec. 31, 2022
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 32 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 25.4 | $163M | 3.2M | 51.71 | |
| Chinook Therapeutics | 10.4 | $67M | 2.6M | 26.20 | |
| Verona Pharma Sponsored Ads (VRNA) | 10.0 | $65M | 2.5M | 26.13 | |
| Arcus Biosciences Incorporated (RCUS) | 8.0 | $51M | 2.5M | 20.68 | |
| Mirati Therapeutics | 5.3 | $34M | 750k | 45.31 | |
| Celldex Therapeutics Com New (CLDX) | 5.3 | $34M | 761k | 44.57 | |
| Iveric Bio | 4.3 | $27M | 1.3M | 21.41 | |
| Miragen Therapeutics (VRDN) | 3.7 | $24M | 824k | 29.21 | |
| Tandem Diabetes Care Com New (TNDM) | 3.3 | $21M | 475k | 44.95 | |
| Aerovate Therapeutics (AVTE) | 2.8 | $18M | 622k | 29.30 | |
| Spdr Ser Tr S&p Biotech (XBI) | 2.6 | $17M | 199k | 83.00 | |
| Vera Therapeutics Cl A (VERA) | 2.0 | $13M | 665k | 19.35 | |
| Intra Cellular Therapies (ITCI) | 1.8 | $12M | 221k | 52.92 | |
| Cymabay Therapeutics | 1.8 | $12M | 1.9M | 6.27 | |
| 4d Molecular Therapeutics In (FDMT) | 1.7 | $11M | 500k | 22.21 | |
| Alpine Immune Sciences (ALPN) | 1.4 | $9.0M | 1.2M | 7.35 | |
| Iteos Therapeutics (ITOS) | 1.4 | $8.7M | 445k | 19.53 | |
| Viking Therapeutics (VKTX) | 1.3 | $8.2M | 871k | 9.40 | |
| Avidity Biosciences Ord (RNA) | 1.1 | $7.2M | 325k | 22.19 | |
| Bridgebio Pharma (BBIO) | 1.1 | $7.1M | 934k | 7.62 | |
| Stoke Therapeutics (STOK) | 1.1 | $7.0M | 764k | 9.23 | |
| Xilio Therapeutics (XLO) | 1.0 | $6.5M | 2.4M | 2.69 | |
| 89bio (ETNB) | 0.8 | $4.8M | 380k | 12.73 | |
| Gossamer Bio (GOSS) | 0.7 | $4.2M | 2.0M | 2.17 | |
| Mirum Pharmaceuticals (MIRM) | 0.3 | $2.0M | 100k | 19.50 | |
| Praxis Precision Medicines I | 0.3 | $1.9M | 800k | 2.38 | |
| Dex (DXCM) | 0.3 | $1.7M | 15k | 113.24 | |
| Prometheus Biosciences | 0.3 | $1.7M | 15k | 110.00 | |
| Jounce Therapeutics | 0.2 | $1.6M | 1.4M | 1.11 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $750k | 1.0M | 0.75 | |
| Nuvalent Inc-a (NUVL) | 0.1 | $745k | 25k | 29.78 | |
| Century Therapeutics (IPSC) | 0.0 | $231k | 45k | 5.13 |
